1. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19;Gao;J Med Virol.,2020
2. Yanga J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. doi: 10.1016/j.ijid.2020.03.017.
3. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis;Lippi;Prog Cardiovasc Dis,2020
4. Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, Montfort JH, Islam AM. Systematic review of COVID-19 related myocarditis: Insights on management and outcome. doi: 10.1016/j.carrev.2020.08.028.
5. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020, doi: 10.1001/jamacardio.2020.1017.e201017.